Immuno-oncology Race Heats Up

False Start for Bristol Myers; Merck Gains the Lead We covered in some detail the fascinating world of immuno-oncology back in our inaugural edition last December. We reviewed the current state of research and how big pharma companies like Bristol…continue reading